TY - JOUR
T1 - Gallbladder motility in agouti-yellow and leptin-resistant obese mice
AU - Tran, Khoi Q.
AU - Swartz-Basile, Deborah A.
AU - Nakeeb, Attila
AU - Pitt, Henry A.
PY - 2003/7
Y1 - 2003/7
N2 - Background. Obesity is a polygenic disorder that is associated with gallstone disease. We have previously shown that leptin deficiency in obese mice correlates with decreased gallbladder motility, suggesting that leptin plays a role in the link between gallstone disease and obesity. However, most obese humans are leptin-resistant, and relatively few are leptin-deficient. To confirm that leptin dysfunction is responsible for impaired gallbladder motility in obese mice, we hypothesized that leptin-resistant obese mice (Lepdb) would have abnormal gallbladder motility while obese mice with intact leptin function (Agouti Yellow, Ay) would have normal gallbladder motility. Materials and methods. Eighteen lean control (C57BL/6J), 10 Ay and 12 Lepdb female mice were fasted overnight, weighed, and livers and gallbladders were harvested. Liver weights and gallbladder volumes were measured. Gallbladder contractile responses (N/cm 2) to acetylcholine (10-5M), neuropeptide Y (10 -8,-7,-6 M) and cholecystokinin (10-10,-9,-8,-7M) were determined in muscle bath chambers. Results were analyzed by analysis of various (ANOVA) and with the Mann-Whitney Rank Sum Test. Results. Both Agouti yellow (Ay) and leptin-resistant (Lepdb) obese mice had body weights, liver weights and gallbladder volumes that were significantly greater (P < 0.01) than lean control mice. Leptin-resistant obese mice had gallbladder responses to acetylcholine, neuropeptide Y and cholecystokinin that were significantly less (P < 0.01) than both lean control and Agouti yellow obese mice. Conclusions. These data suggest that (1) leptin-resistant obese mice (Lepdb) have abnormal gallbladder motility and (2) obese mice with normal leptin metabolism (Ay) have normal gallbladder response to neurotransmitters. We conclude that leptin represents a link between obesity, gallbladder motility and gallstone formation.
AB - Background. Obesity is a polygenic disorder that is associated with gallstone disease. We have previously shown that leptin deficiency in obese mice correlates with decreased gallbladder motility, suggesting that leptin plays a role in the link between gallstone disease and obesity. However, most obese humans are leptin-resistant, and relatively few are leptin-deficient. To confirm that leptin dysfunction is responsible for impaired gallbladder motility in obese mice, we hypothesized that leptin-resistant obese mice (Lepdb) would have abnormal gallbladder motility while obese mice with intact leptin function (Agouti Yellow, Ay) would have normal gallbladder motility. Materials and methods. Eighteen lean control (C57BL/6J), 10 Ay and 12 Lepdb female mice were fasted overnight, weighed, and livers and gallbladders were harvested. Liver weights and gallbladder volumes were measured. Gallbladder contractile responses (N/cm 2) to acetylcholine (10-5M), neuropeptide Y (10 -8,-7,-6 M) and cholecystokinin (10-10,-9,-8,-7M) were determined in muscle bath chambers. Results were analyzed by analysis of various (ANOVA) and with the Mann-Whitney Rank Sum Test. Results. Both Agouti yellow (Ay) and leptin-resistant (Lepdb) obese mice had body weights, liver weights and gallbladder volumes that were significantly greater (P < 0.01) than lean control mice. Leptin-resistant obese mice had gallbladder responses to acetylcholine, neuropeptide Y and cholecystokinin that were significantly less (P < 0.01) than both lean control and Agouti yellow obese mice. Conclusions. These data suggest that (1) leptin-resistant obese mice (Lepdb) have abnormal gallbladder motility and (2) obese mice with normal leptin metabolism (Ay) have normal gallbladder response to neurotransmitters. We conclude that leptin represents a link between obesity, gallbladder motility and gallstone formation.
KW - Acetylcholine
KW - Agouti yellow
KW - Cholecystokinin
KW - Gallbladder disease
KW - Gallbladder motility
KW - Gallstone
KW - Lep
KW - Leptin
KW - Neuropeptide Y
KW - Obesity
UR - http://www.scopus.com/inward/record.url?scp=0042490524&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042490524&partnerID=8YFLogxK
U2 - 10.1016/S0022-4804(03)00157-4
DO - 10.1016/S0022-4804(03)00157-4
M3 - Article
C2 - 12943811
AN - SCOPUS:0042490524
SN - 0022-4804
VL - 113
SP - 56
EP - 61
JO - Journal of Surgical Research
JF - Journal of Surgical Research
IS - 1
ER -